Compugen Stock

Compugen Change in Working Capital

The Change in Working Capital of Compugen (CGEN) as of Aug 10, 2026 is -5.35 M USD. In the previous year, Change in Working Capital was 62.05 M USD — a change of -108.62% (lower).

Change in Working Capital

-5.35 MUSD

YoY

-108.62%

Last updated:

Change in Working Capital of Compugen is 2026 -5.35 M USD. Change in Working Capital of Compugen was 2025 62.05 M USD. It decreases by -108.62% lower compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Change in Working Capital of Compugen is -5.35 M USD in 2026.

Change in Working Capital of Compugen changed from 62.05 M USD to -5.35 M USD, representing a -108.62% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Change in Working Capital Compugen since 2006 – with annual values, charts, and detailed analysis.

Change in working capital reflects the period-over-period change in current assets minus current liabilities. It impacts operating cash flow significantly.

Change in Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Change in Working Capital's Compugen historically and in real time.

Access this data via the Eulerpool API

Cash Flow — Compugen

All Key Metrics — Compugen